Bangalore (and US) based Biotech research company, GangaGen has raised $1.8mn from ATEL ventures.
The funding will be used to develop treatments for antibiotic-resistant bacterial infections like MRSA, a skin infection that plagues hospitals, and pneumonia (via)
Recommended Read: Green Tech Investments in India | The Great Indian Energy Innovation!
